Literature DB >> 10447463

Expression of GDNF and GDNFR-alpha mRNAs in muscles of patients with motor neuron diseases.

M Yamamoto1, N Mitsuma, A Inukai, Y Ito, M Li, T Mitsuma, G Sobue.   

Abstract

The mRNA expression levels of GDNF, GDNFR-alpha and RET were examined in the muscles of amyotrophic lateral screlosis (ALS) and X-linked spinal and bulbar muscular atrophy (SBMA). GDNF mRNA levels were significantly elevated to variable extent in the diseased muscles compared to control muscles, although they were not specific to the type of the diseases. The diseased muscles also have a different expression pattern of GDNF mRNA isoforms from controls. GDNF mRNA expression, however, tended to reduce in advanced muscle pathology. On the other hand, GDNFR-alpha mRNA levels were not changed significantly on expression levels in the diseased muscles. In situ hybridization study revealed that GDNF and GDNFR-alpha mRNAs were localized in subsarcolemmal space of muscle cells. RET mRNA was not detected in control nor diseased muscles. These results suggest that the elevated muscle GDNF acts as a trophic signal for motor neurons of motor neuron diseases, implying a possible therapeutic implication of GDNF to this type of diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447463     DOI: 10.1023/a:1020739831778

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

1.  Characterization of a multicomponent receptor for GDNF.

Authors:  J J Treanor; L Goodman; F de Sauvage; D M Stone; K T Poulsen; C D Beck; C Gray; M P Armanini; R A Pollock; F Hefti; H S Phillips; A Goddard; M W Moore; A Buj-Bello; A M Davies; N Asai; M Takahashi; R Vandlen; C E Henderson; A Rosenthal
Journal:  Nature       Date:  1996-07-04       Impact factor: 49.962

2.  Functional receptor for GDNF encoded by the c-ret proto-oncogene.

Authors:  M Trupp; E Arenas; M Fainzilber; A S Nilsson; B A Sieber; M Grigoriou; C Kilkenny; E Salazar-Grueso; V Pachnis; U Arumäe
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

3.  GDNF signalling through the Ret receptor tyrosine kinase.

Authors:  P Durbec; C V Marcos-Gutierrez; C Kilkenny; M Grigoriou; K Wartiowaara; P Suvanto; D Smith; B Ponder; F Costantini; M Saarma
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

4.  Founder effect in spinal and bulbar muscular atrophy (SBMA).

Authors:  F Tanaka; M Doyu; Y Ito; M Matsumoto; T Mitsuma; K Abe; M Aoki; Y Itoyama; K H Fischbeck; G Sobue
Journal:  Hum Mol Genet       Date:  1996-09       Impact factor: 6.150

5.  Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues.

Authors:  M Yamamoto; G Sobue; K Yamamoto; S Terao; T Mitsuma
Journal:  Neurochem Res       Date:  1996-08       Impact factor: 3.996

6.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

7.  GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF.

Authors:  S Jing; D Wen; Y Yu; P L Holst; Y Luo; M Fang; R Tamir; L Antonio; Z Hu; R Cupples; J C Louis; S Hu; B W Altrock; G M Fox
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

8.  IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life.

Authors:  D C Molliver; D E Wright; M L Leitner; A S Parsadanian; K Doster; D Wen; Q Yan; W D Snider
Journal:  Neuron       Date:  1997-10       Impact factor: 17.173

9.  cDNA sequence and differential mRNA regulation of two forms of glial cell line-derived neurotrophic factor in Schwann cells and rat skeletal muscle.

Authors:  J E Springer; J L Seeburger; J He; A Gabrea; E P Blankenhorn; L W Bergman
Journal:  Exp Neurol       Date:  1995-01       Impact factor: 5.330

10.  Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain.

Authors:  K D Beck; J Valverde; T Alexi; K Poulsen; B Moffat; R A Vandlen; A Rosenthal; F Hefti
Journal:  Nature       Date:  1995-01-26       Impact factor: 49.962

View more
  13 in total

1.  Androgen-dependent loss of muscle BDNF mRNA in two mouse models of SBMA.

Authors:  Katherine Halievski; Casey L Henley; Laurel Domino; Jessica E Poort; Martina Fu; Masahisa Katsuno; Hiroaki Adachi; Gen Sobue; S Marc Breedlove; Cynthia L Jordan
Journal:  Exp Neurol       Date:  2015-04-27       Impact factor: 5.330

Review 2.  The complex molecular biology of amyotrophic lateral sclerosis (ALS).

Authors:  Rachel L Redler; Nikolay V Dokholyan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  In vivo gene electroporation of glial cell line-derived neurotrophic factor (GDNF) into skeletal muscle of SOD1 mutant mice.

Authors:  M Yamamoto; Y Kobayashi; M Li; H Niwa; N Mitsuma; Y Ito; T Muramatsu; G Sobue
Journal:  Neurochem Res       Date:  2001-11       Impact factor: 3.996

4.  Specific Expression of Glial-Derived Neurotrophic Factor in Muscles as Gene Therapy Strategy for Amyotrophic Lateral Sclerosis.

Authors:  Guillem Mòdol-Caballero; Mireia Herrando-Grabulosa; Belén García-Lareu; Sergi Verdés; Rubén López-Vales; Gemma Pagès; Miguel Chillón; Xavier Navarro; Assumpció Bosch
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

Review 5.  Neurotrophic factors in neurodegenerative disorders : potential for therapy.

Authors:  Fabio Fumagalli; Raffaella Molteni; Francesca Calabrese; Paola Francesca Maj; Giorgio Racagni; Marco Andrea Riva
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model.

Authors:  Shruthi Shanmukha; Gayathri Narayanappa; Atchayaram Nalini; Phalguni Anand Alladi; Trichur R Raju
Journal:  Dis Model Mech       Date:  2018-04-16       Impact factor: 5.758

7.  Vrk1 partial Knockdown in Mice Results in Reduced Brain Weight and Mild Motor Dysfunction, and Indicates Neuronal VRK1 Target Pathways.

Authors:  Hadar Vinograd-Byk; Paul Renbaum; Ephrat Levy-Lahad
Journal:  Sci Rep       Date:  2018-07-26       Impact factor: 4.379

Review 8.  New routes to therapy for spinal and bulbar muscular atrophy.

Authors:  Anna Rocchi; Maria Pennuto
Journal:  J Mol Neurosci       Date:  2013-02-19       Impact factor: 3.444

9.  Mechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction.

Authors:  Lenore K Beitel; Carlos Alvarado; Shaza Mokhtar; Miltiadis Paliouras; Mark Trifiro
Journal:  Front Neurol       Date:  2013-05-15       Impact factor: 4.003

10.  A Role for GDNF and Soluble APP as Biomarkers of Amyotrophic Lateral Sclerosis Pathophysiology.

Authors:  Serena Stanga; Liliana Brambilla; Bernadette Tasiaux; Anh H Dang; Adrian Ivanoiu; Jean-Noël Octave; Daniela Rossi; Vincent van Pesch; Pascal Kienlen-Campard
Journal:  Front Neurol       Date:  2018-05-30       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.